Table 1.
Means and Proportions of Demographics, Biological Age, Biomarkers, and Outcomes at Year 20, Overall and by Race/Sex Categories: CARDIA 2005–2006
| Total (n = 2984) m (sd) or % | Black Women (n = 825) m (sd) or % | Black Men (n = 505) m (sd) or % | White Women (n = 885) m (sd) or % | White Men (n = 769) m (sd) or % | |
|---|---|---|---|---|---|
| 45.3 (3.6) | 44.6 (3.8) | 44.6 (3.8) | 45.8 (3.4) | 45.8 (3.4) | |
| Biological Age | 45.1 (9.2) | 47.3 (9.9) | 46.4 (9.0) | 43.5 (8.40) | 43.6 (8.8) |
| Accelerated Aging | −0.2 (8.5) | 2.7 (8.6) | 1.8 (8.4) | −2.3 (7.6) | −2.1 (8.1) |
| Current Smoker | 17.7% | 21.0% | 27.3% | 12.5% | 14.1% |
| mL Alcohol/week | 10.9 (21.9) | 5.3 (14.6) | 14.1 (30.8) | 10.0 (15.2) | 15.9 (26.2) |
| Exercise score (EU) | 343.2 (274.7) | 227.9 (220.4) | 410.3 (330.5) | 343.9 (256.1) | 421.3 (265.5) |
| Total Cholesterol (mg/dL) | 186.3 (34.8) | 185.1 (34.7) | 183.4 (37.1) | 187.0 (31.7) | 188.8 (36.6) |
| HDL Cholesterol (mg/dL) | 54.3 (16.6) | 57.5 (15.8) | 49.4 (15.3) | 61.4 (16.8) | 45.9 (12.8) |
| Glucose (mg/dL) | 97.3 (24.3) | 98.1 (30.8) | 101.6 (27.5) | 91.8 (14.8) | 100.1 (22.0) |
| Waist-to-hip ratio | 0.8 (0.1) | 0.8 (0.1) | 0.9 (0.1) | 0.8 (0.1) | 0.9 (0.1) |
| C-reactive protein (mg/L) | 2.7 (4.5) | 4.2 (5.5) | 2.5 (4.7) | 2.4 (4.2) | 1.4 (2.4) |
| FEV1/h2 (liters) | 3.1 (0.8) | 2.4 (0.5) | 3.2 (0.6) | 2.9 (0.5) | 3.9 (0.6) |
| Mean arterial pressure (mmHg) | 87.3(12.0) | 90.1 (13.0) | 92.3 (11.3) | 81.6 (10.5) | 87.5 (10.2) |
| Outcomes [incidence rate 2007–2018 (average time to outcome, in years)] | |||||
| Cardiovascular Disease | 0.007 (9.7) | 0.009 (8.6) | 0.010 (9.5) | 0.004 (9.8) | 0.007 (9.6) |
| Stroke | 0.001 (9.9) | 0.002 (9.9) | 0.002 (9.9) | 0.0002 (10.0) | 0.001 (10.0) |
| Mortality | 0.001 (10.0) | 0.001 (10.0) | 0.001 (10.0) | 0.001 (10.0) | 0.001 (10.0) |
FEV1/h2 = Forced expiratory volume in 1 second/height2; EU = Exercise Units
CVD includes myocardial infarction, coronary revascularization, non-MI acute coronary syndrome, chronic heart failure, stroke, deep vein thrombosis, pulmonary embolism, and atrial fibrillation/atrial flutter, and death attributed to CVD